Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

PetMed Express, Inc. (PETS) had Revenue of $281.06M for the most recently reported fiscal year, ending 2024-03-31.

Quarterly Annual

Figures for fiscal year ending 2024-03-31

Income Statement Financials
Revenue	$281.06M
Net Income	$-7.46M
Cost of Goods Sold	$202.42M
Gross Profit	$78.65M
Operating Expenses	$289.23M
Operating Income	$-8.16M
Non-Operating Income/Expense	$1.89M
Pre-Tax Income	$-6.27M
Normalized Pre-Tax Income	$-6.27M
Income after Taxes	$-7.46M
Income from Continuous Operations	$-7.46M
Consolidated Net Income/Loss	$-7.46M
Normalized Income after Taxes	$-7.46M
EBIT	$-8.16M
EBITDA	$-1.11M
Weighted-Average Shares Outstanding (Basic)	20.40M
Weighted-Average Shares Outstanding (Diluted)	20.40M
Earnings per Share (EPS) (Basic)	$-0.37
Earnings per Share (EPS) (Diluted)	$-0.37
Balance Sheet Financials
Current Assets	$93.65M
Property, Plant, and Equipment	$26.66M
Long-Term Assets	$76.24M
Total Assets	$169.88M
Current Liabilities	$72.16M
Long-Term Debt	--
Long-Term Liabilities	$0.99M
Total Liabilities	$73.15M
Common Equity	$96.72M
Tangible Shareholders Equity	$53.57M
Shareholders Equity	$96.73M
Common Shares Outstanding	21.15M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$4.32M
Cash Flow from Investing Activities	$-40.67M
Cash Flow from Financial Activities	$-12.44M
Beginning Cash	$104.09M
End Cash	$55.30M
Increase/Decrease in Cash	$-48.79M
Stock-Based Compensation	$6.87M
Common Stock Dividends Paid	$-12.44M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.30
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	--
Debt to Equity Ratio	--
Gross Margin	27.98%
Operating Margin	-2.90%
EBIT Margin	-2.90%
EBITDA Margin	-0.39%
Pre-Tax Profit Margin	-2.23%
Profit Margin	-2.66%
Free Cash Flow	$-0.19M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	1.65
Inventory Turnover	7.09
Receiveable Turnover	85.61
Days Sales in Receivables	4.26
Return on Equity	-7.72%
Return on Tangible Equity	-13.93%
Return on Assets	-4.39%
Return on Investments	-7.72%
Book Value Per Share	$4.57
Free Cash Flow per Share	$-0.01
Operating Cash Flow per Share	$0.21

Data from Zacks Investment Research, Inc.